Terms: = Pancreatic cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
44 results:
1. Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC.
Wang J; Zhang T; Li P; Gai J; Chen S; Espinoza G; Kung HC; Zhang R; Fujiwara K; Fu J; Yu J; Zheng L
Cancer Lett; 2023 Oct; 573():216366. PubMed ID: 37640197
[TBL] [Abstract] [Full Text] [Related]
2. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen.
Chen P; Chen D; Bu D; Gao J; Qin W; Deng K; Ren L; She S; Xu W; Yang Y; Xie X; Liao W; Chen H
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37076248
[TBL] [Abstract] [Full Text] [Related]
3. Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study.
Wen C; Zhang L; Yang Y; Jin Y; Ren D; Zhang Z; Zou S; Li F; Sun H; Jin J; Lu X; Xie J; Cheng D; Xu Z; Chen H; Mao B; Zhang J; Wang J; Deng X; Peng C; Li H; Jiang C; Lin L; Zhang H; Chen H; Shen B; Zhan Q
Int J Surg; 2023 Jul; 109(7):1941-1952. PubMed ID: 37026827
[TBL] [Abstract] [Full Text] [Related]
4. Prediction Model with
Nishida N; Ohashi J; Suda G; Chiyoda T; Tamaki N; Tomiyama T; Ogasawara S; Sugiyama M; Kawai Y; Khor SS; Nagasaki M; Fujimoto A; Tsuchiura T; Ishikawa M; Matsuda K; Yano H; Yoshizumi T; Izumi N; Hasegawa K; Sakamoto N; Mizokami M; Tokunaga K
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902191
[TBL] [Abstract] [Full Text] [Related]
5. The Detection of Immunity against WT1 and SMAD4
Koya T; Niida Y; Togi M; Yoshida K; Sakamoto T; Ura H; Togi S; Kato T; Yamada S; Sugiyama H; Koido S; Shimodaira S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293034
[TBL] [Abstract] [Full Text] [Related]
6. Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.
Kim GB; Fritsche J; Bunk S; Mahr A; Unverdorben F; Tosh K; Kong H; Maldini CR; Lau C; Srivatsa S; Jiang S; Glover J; Dopkin D; Zhang CX; Schuster H; Kowalewski DJ; Goldfinger V; Ott M; Fuhrmann D; Baues M; Boesmueller H; Schraeder C; Schimmack G; Song C; Hoffgaard F; Roemer M; Tsou CC; Hofmann M; Treiber T; Hutt M; Alten L; Jaworski M; Alpert A; Missel S; Reinhardt C; Singh H; Schoor O; Walter S; Wagner C; Maurer D; Weinschenk T; Riley JL
Sci Transl Med; 2022 Aug; 14(660):eabo6135. PubMed ID: 36044599
[TBL] [Abstract] [Full Text] [Related]
7. The age-dependent association of risk factors with pancreatic cancer.
Yuan C; Kim J; Wang QL; Lee AA; Babic A; ; Amundadottir LT; Klein AP; Li D; McCullough ML; Petersen GM; Risch HA; Stolzenberg-Solomon RZ; Perez K; Ng K; Giovannucci EL; Stampfer MJ; Kraft P; Wolpin BM
Ann Oncol; 2022 Jul; 33(7):693-701. PubMed ID: 35398288
[TBL] [Abstract] [Full Text] [Related]
8. The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma.
Herremans KM; Szymkiewicz DD; Riner AN; Bohan RP; Tushoski GW; Davidson AM; Lou X; Leong MC; Dean BD; Gerber M; Underwood PW; Han S; Hughes SJ
Neoplasia; 2022 Jun; 28():100789. PubMed ID: 35395492
[TBL] [Abstract] [Full Text] [Related]
9. TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
Sengupta S; Board NL; Wu F; Moskovljevic M; Douglass J; Zhang J; Reinhold BR; Duke-Cohan J; Yu J; Reed MC; Tabdili Y; Azurmendi A; Fray EJ; Zhang H; Hsiue EH; Jenike K; Ho YC; Gabelli SB; Kinzler KW; Vogelstein B; Zhou S; Siliciano JD; Sadegh-Nasseri S; Reinherz EL; Siliciano RF
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2123406119. PubMed ID: 35394875
[TBL] [Abstract] [Full Text] [Related]
10. Targeting a neoantigen derived from a common
Hsiue EH; Wright KM; Douglass J; Hwang MS; Mog BJ; Pearlman AH; Paul S; DiNapoli SR; Konig MF; Wang Q; Schaefer A; Miller MS; Skora AD; Azurmendi PA; Murphy MB; Liu Q; Watson E; Li Y; Pardoll DM; Bettegowda C; Papadopoulos N; Kinzler KW; Vogelstein B; Gabelli SB; Zhou S
Science; 2021 Mar; 371(6533):. PubMed ID: 33649166
[No Abstract] [Full Text] [Related]
11. Engineering Tolerance toward Allogeneic CAR-T Cells by Regulation of MHC Surface Expression with Human Herpes Virus-8 Proteins.
Wang X; Cabrera FG; Sharp KL; Spencer DM; Foster AE; Bayle JH
Mol Ther; 2021 Feb; 29(2):718-733. PubMed ID: 33554868
[TBL] [Abstract] [Full Text] [Related]
12. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
Bradley SD; Talukder AH; Lai I; Davis R; Alvarez H; Tiriac H; Zhang M; Chiu Y; Melendez B; Jackson KR; Katailiha A; Sonnemann HM; Li F; Kang Y; Qiao N; Pan BF; Lorenzi PL; Hurd M; Mittendorf EA; Peterson CB; Javle M; Bristow C; Kim M; Tuveson DA; Hawke D; Kopetz S; Wolff RA; Hwu P; Maitra A; Roszik J; Yee C; Lizée G
Nat Commun; 2020 Oct; 11(1):5332. PubMed ID: 33087697
[TBL] [Abstract] [Full Text] [Related]
13. Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression.
Wen L; Zou X; Chen Y; Bai X; Liang T
Front Immunol; 2020; 11():2076. PubMed ID: 32973816
[TBL] [Abstract] [Full Text] [Related]
14. Tumor Microenvironment Immune Response in pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy.
Michelakos T; Cai L; Villani V; Sabbatino F; Kontos F; Fernández-Del Castillo C; Yamada T; Neyaz A; Taylor MS; Deshpande V; Kurokawa T; Ting DT; Qadan M; Weekes CD; Allen JN; Clark JW; Hong TS; Ryan DP; Wo JY; Warshaw AL; Lillemoe KD; Ferrone S; Ferrone CR
J Natl Cancer Inst; 2021 Feb; 113(2):182-191. PubMed ID: 32497200
[TBL] [Abstract] [Full Text] [Related]
15. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
16. Role of Tumor-Associated Macrophages in the Clinical Course of pancreatic Neuroendocrine Tumors (PanNETs).
Cai L; Michelakos T; Deshpande V; Arora KS; Yamada T; Ting DT; Taylor MS; Castillo CF; Warshaw AL; Lillemoe KD; Ferrone S; Ferrone CR
Clin Cancer Res; 2019 Apr; 25(8):2644-2655. PubMed ID: 30670493
[TBL] [Abstract] [Full Text] [Related]
17. Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study.
Nishida S; Ishikawa T; Egawa S; Koido S; Yanagimoto H; Ishii J; Kanno Y; Kokura S; Yasuda H; Oba MS; Sato M; Morimoto S; Fujiki F; Eguchi H; Nagano H; Kumanogoh A; Unno M; Kon M; Shimada H; Ito K; Homma S; Oka Y; Morita S; Sugiyama H
Cancer Immunol Res; 2018 Mar; 6(3):320-331. PubMed ID: 29358173
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic cancer: Next-generation algorithms for neoantigen selection.
Hopkins A; Jaffee E
Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):135-136. PubMed ID: 29317775
[TBL] [Abstract] [Full Text] [Related]
19. Characterising
Zhang M; Lykke-Andersen S; Zhu B; Xiao W; Hoskins JW; Zhang X; Rost LM; Collins I; Bunt MV; Jia J; Parikh H; Zhang T; Song L; Jermusyk A; Chung CC; Zhu B; Zhou W; Matters GL; Kurtz RC; Yeager M; Jensen TH; Brown KM; Ongen H; Bamlet WR; Murray BA; McCarthy MI; Chanock SJ; Chatterjee N; Wolpin BM; Smith JP; Olson SH; Petersen GM; Shi J; Amundadottir L
Gut; 2018 Mar; 67(3):521-533. PubMed ID: 28634199
[TBL] [Abstract] [Full Text] [Related]
20. Aggravation of diabetes, and incompletely deficient insulin secretion in a case with type 1 diabetes-resistant human leukocyte antigen DRB1*15:02 treated with nivolumab.
Matsumura K; Nagasawa K; Oshima Y; Kikuno S; Hayashi K; Nishimura A; Okubo M; Uruga H; Kishi K; Kobayashi T; Mori Y
J Diabetes Investig; 2018 Mar; 9(2):438-441. PubMed ID: 28418115
[TBL] [Abstract] [Full Text] [Related]
[Next]
